Attributes | Values |
---|
rdf:type
| |
Description
| - Adefovir (9-(2-fosfonomethoxyethyl)adenin) je acyklický fosfonát nukleosidu užívaný v praxi pro léčbu hetatitidy B. Cílem této studie bylo stanovení vlivu aktivátoru průniku DDAK (dodecyl ester 6-dimethylaminohexanové kyseliny) na transdermální a topickou aplikaci adefoviru. (cs)
- Adefovir (9-(2-phosphonomethoxyethyl)adenine) is an acyclic nucleoside phosphonate currently used for the treatment of hepatitis B. The aim of this study was to evaluate the effect of permeation enhancer DDAK (6-dimethylaminohaxanoic acid dodecyl ester) on the transdermal and topical delivery of adefovir.
- Adefovir (9-(2-phosphonomethoxyethyl)adenine) is an acyclic nucleoside phosphonate currently used for the treatment of hepatitis B. The aim of this study was to evaluate the effect of permeation enhancer DDAK (6-dimethylaminohaxanoic acid dodecyl ester) on the transdermal and topical delivery of adefovir. (en)
|
Title
| - Permeation enhancer dedocyl 6-(dimethylamino)hexanoate increases transdermal and topical delivery of adefovir: Influence of pH, ion-pairing and skin species
- Permeation enhancer dedocyl 6-(dimethylamino)hexanoate increases transdermal and topical delivery of adefovir: Influence of pH, ion-pairing and skin species (en)
- Aktivátor průniku dodecycl 6-(dimethylamino)hexanoát zlepšuje transdermální a topickou aplikaci adefoviru: Vliv pH, párování iontů a druhu kůže (cs)
|
skos:prefLabel
| - Permeation enhancer dedocyl 6-(dimethylamino)hexanoate increases transdermal and topical delivery of adefovir: Influence of pH, ion-pairing and skin species
- Permeation enhancer dedocyl 6-(dimethylamino)hexanoate increases transdermal and topical delivery of adefovir: Influence of pH, ion-pairing and skin species (en)
- Aktivátor průniku dodecycl 6-(dimethylamino)hexanoát zlepšuje transdermální a topickou aplikaci adefoviru: Vliv pH, párování iontů a druhu kůže (cs)
|
skos:notation
| - RIV/61388963:_____/08:00314920!RIV09-AV0-61388963
|
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| - P(1M0508), S, Z(AV0Z40550506), Z(MSM0021620822)
|
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/61388963:_____/08:00314920
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - adefovir; acyclic nucleoside phosphonates; antiviral; transdermal drug delivery; permeation enhancer (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| |
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| - European Journal of Pharmaceutics and Biopharmaceutics
|
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...vavai/riv/projekt
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Holý, Antonín
- Novotný, J.
- Vávrová, K.
- Hrabálek, A.
- Lorencová, K.
|
http://linked.open...ain/vavai/riv/wos
| |
http://linked.open...n/vavai/riv/zamer
| |
issn
| |
number of pages
| |